Pharmacokinetics of Neostigmine and Glycopyrrolate

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

March 9, 2020

Primary Completion Date

December 20, 2022

Study Completion Date

December 20, 2022

Conditions

Spinal Cord InjuriesConstipationFecal IncontinenceNeurogenic Bowel

Interventions

DRUG

Combination of Neostigmine and Glycopyrrolate

Intravenous or transdermal

DEVICE

I-Box by Dynatronics

Electric field conducting drugs through the skin without compromising its integrity

Trial Locations (1)

James J Peters VA Medical Center, The Bronx

All Listed Sponsors

lead

James J. Peters Veterans Affairs Medical Center

FED

NCT04027972 - Pharmacokinetics of Neostigmine and Glycopyrrolate | Biotech Hunter | Biotech Hunter